Back to trial details

Intake questionnaire

SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver Disease

Applying to Ann & Robert H Lurie Children's Hospital of Chicago · Chicago, Illinois

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you between 12 and 20 years old?
2. Have you been diagnosed with Non-Alcoholic Fatty Liver Disease?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to Chicago for study visits?